Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 08 - 09 symbols : Alny save search
Dicerna Announces Second Quarter 2021 Financial Results and Provides a Business Update
Published: 2021-08-09 (Crawled : 12:15) - biospace.com/
NVO | $123.9 -0.49% 0.23% 2.9M
|
Health Technology
|
| O: 1.64%
H: 0.89%
C: 0.58%
LLY | $750.77 -0.12% 0.0% 2.3M
|
Health Technology
|
| O: 0.33%
H: 3.2%
C: 0.98%
ALNY | $147.775 -0.49% -0.49% 490K
|
Health Technology
|
| O: 0.37%
H: 4.18%
C: 3.46%
financial results results
Alnylam Completes Enrollment in HELIOS-B Phase 3 Study of Investigational Vutrisiran in Patients with Transthyretin-Mediated (ATTR) Amyloidosis with Cardiomyopathy
Published: 2021-08-09 (Crawled : 12:15) - biospace.com/
ALNY | $147.775 -0.49% -0.49% 490K
|
Health Technology
|
| O: 0.37%
H: 4.18%
C: 3.46%
media phase 3 cardio enroll
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M
|
Wholesale Trade
PXMD | $0.7375 79.09% 44.16% 4.5M
|
Health Technology
DYNT | $0.371 -5.12% 43.09% 3.3M
|
Health Technology
LGVN P 3 d | $2.94 73.96% 42.52% 57M
|
HUBC | $1.94 49.23% 32.99% 73M
|
n/a
SPCB | $0.4044 46.52% 31.75% 130M
|
Electronic Technology
ONVO | $1.34 32.66% 24.62% 54M
|
Health Technology
OMQS | $0.6869 32.1% 24.3% 3.6M
|
Professional, Scientific, and T...
SNPO | $10.555 29.67% 22.88% 4M
|
AMBI | $3.72 -26.77% 21.77% 9.8K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.